This excerpt taken from the TPTX 8-K filed Oct 10, 2006.
3.1 License Grant. Subject to the terms and conditions of this Agreement, LSRI hereby grants to Neurogenetics and its Affiliates during the Term an exclusive (even as to LSRI), worldwide, royalty bearing license, with the right to sublicense through multiple tiers of sublicense, under the Licensed Technology and Research Technology to research, develop, make, have made, use, sell, offer for sale, have sold and import Licensed Products and Additional Products in the Field; provided however, that LSRI retains the right to conduct research using Licensed Compounds and Additional Compounds to the extent provided in the Research Plan, which may not be transferred. In the event that an Affiliate of Neurogenetics is given access to the Licensed Technology by Neurogenetics, Neurogenetics shall provide prompt notice to LSRI of the grant of such access. For clarification, LSRI retains all rights under the Licensed Technology other than the rights to research, develop, make, have made, use, sell, offer for sale, have sold and import Licensed Products and Additional Products in the Field licensed to Neurogenetics under this Section 3.1.